Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProSciento is an active, privately held full-service clinical research organization specializing in metabolic diseases including diabetes, obesity, NAFLD/NASH. Founded as Profil Institute for Clinical Research in San Diego in 2003 and rebranded as ProSciento in January 2017, it has conducted over 300 clinical projects globally. The company offers comprehensive early-phase to late-phase trial support—including protocol design, regulatory planning, patient recruitment via specialized registries like NASH PASS™, data management and publication support—for biopharma and medtech companies developing novel therapeutics or devices targeting metabolic disorders. It partners with both large pharma and emerging biotech firms worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProSciento.